Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

SP 600125, Tocris Bioscience™

Catalog No. p-4785598 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Selective JNK inhibitor

SP 600125 is a selective JNK inhibitor. Competitively and reversibly inhibits JNK1, 2 and 3 (IC50 = 40 - 90 nM) with negligible activity at ERK2, p38β and a range of enzymes. Active in vivo. Exhibits reduced selectivity over other protein kinases under certain conditions. SP 600125 protects renal tubular epithelial cells from ischemia/reperfusion-induced apoptosis. Promotes chondrogenesis of bone mesenchymal stem cells by inhibition of TNF-α-induced inflammation. Adipogenesis from MSCs is also promoted by SP 600125. Essential component of medium for maintaining stem cells in naive pluripotent state.

Chemical Identifiers

CAS 129-56-6
Molecular Formula C14H8N2O
Molecular Weight (g/mol) 220.231
InChI Key ACPOUJIDANTYHO-UHFFFAOYSA-N
Synonym 1,9-pyrazoloanthrone, pyrazolanthrone, dibenzo cd,g indazol-6 2h-one, pyrazoleanthrone, anthra 1,9-cd pyrazol-6 2h-one, anthra-1,9-pyrazol-6-none, 2h-dibenzo cd,g indazol-6-one, jnk inhibitor ii, sapk inhibitor ii
PubChem CID 8515
SMILES C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O

Specifications

Quantity 10 mg
Formula Weight 220.23
Percent Purity >98%
Chemical Name or Material SP 600125
Recommended Storage Desiccate at -20°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.